Public disclosure of inside information according to article 17 MAR

Leo International Precision Health Aktiengesellschaft: New Management Board appointed

Düsseldorf (pta023/23.05.2025/16:15 UTC+2)

The Supervisory Board of the Leo International Precision Health AG has appointed Dr. Joshua Lo to the Management Board with immediate effect in its meeting of 23 May 2025. Dr. Joshua Lo was appointed as Chief Executive Officer.

(end)

---

Emitter:	Leo International Precision Health Aktiengesellschaft Dieselstraße 21 85748 Garching Germany
Contact Person:	Phillip Campbell
E-Mail:	vorstand@spobag-ag.de
ISIN(s):	DE0005490601 (Share)
Stock Exchange(s):	Regulated Market in Dusseldorf, Frankfurt

[ source: https://www.pressetext.com/news/1748009700627 ]

(c) pressetext Nachrichtenagentur GmbH Ad-hoc and financial news distributed by pressetext. Archive: https://www.pressetext.com/channel/Adhoc The emitter is responsible for the content. Contact: adhoc@pressetext.com or +43-1-81140-0.